Amundi Russell 2000 UCITS ETF - USD (C)

Amundi Russell 2000 UCITS ETF - USD (C) is an exchange-traded fund (ETF) from Amundi, traded under the ticker RS2U (ISIN LU1681038839). In a single purchase you get a diversified basket of holdings rather than a stake in just one business. In plain terms it is about owning small slices of companies, so you share in their growth when they do well — and their falls when they don't, spread across its target market. It follows the Russell 2000 Net 30% Total Ret index (passive investing): it tracks the market rather than relying on a manager, keeping running costs down, and its largest holdings include MOOG INC-CL A, CYTOKINETICS INC and BRIGHTSPRING HEALTH SERVICES. By geography it is weighted towards ~100% United States. By industry it concentrates most in ~20.5% Health Care and ~18.9% Financials. It is commonly used to tilt a portfolio towards one market, usually alongside broader, more global funds rather than on its own. Its ongoing charge (TER) is 0.35% a year — about €35 a year on a €10,000 holding, taken automatically from the fund. Income such as dividends is automatically reinvested inside the fund (an accumulating share class), so returns compound without you doing anything. It tracks its index through a swap agreement rather than owning every holding (synthetic replication); it is domiciled in Luxembourg and UCITS-regulated, a European standard built to protect everyday investors and trades in USD. Its price has swung about 18.4% over the past year, which describes how much its price tends to move rather than whether it is good. It launched in 2018. As with any investment, its value can go down as well as up, and past performance is not a guide to future results. (Fund data sourced from Amundi.)